Chemoreduction for retinoblastoma. Analysis of tumor control and risks for recurrence in 457 tumors
Authors:
- Carol L. ShieldsCSCarol L. Shields
- Arman MashayekhiAMArman Mashayekhi
- Jacqueline CaterJCJacqueline Cater
- Abdallah ShelilASAbdallah Shelil
- Anna T. MeadowsAMAnna T. Meadows
- Jerry A. ShieldsJSJerry A. Shields
- 1 September 2004
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 138 (3) , 329-337
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- New retinoblastoma tumor formation in children initially treated with systemic carboplatinOphthalmology, 2003
- DiscussionOphthalmology, 2003
- Chemothermotherapy in the management of retinoblastoma1 1None of the authors have any financial interests in the drugs or devices described in this article.Ophthalmology, 2002
- Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleationAmerican Journal of Ophthalmology, 2002
- Chemotherapy for retinoblastomaMedical and Pediatric Oncology, 2002
- Multiagent chemotherapy as neoadjuvant treatment for multifocal intraocular retinoblastomaOphthalmology, 2001
- Chemotherapy Plus Local Treatment in the Management of Intraocular RetinoblastomaArchives of Ophthalmology (1950), 1996
- Results of Combined Chemotherapy and Radiotherapy for Advanced Intraocular RetinoblastomaArchives of Ophthalmology (1950), 1996
- Chemoreduction in the Initial Management of Intraocular RetinoblastomaArchives of Ophthalmology (1950), 1996
- Chemotherapy With Focal Therapy Can Cure Intraocular Retinoblastoma Without RadiotherapyArchives of Ophthalmology (1950), 1996